PARODI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 1.752
AS - Asia 153
NA - Nord America 60
SA - Sud America 23
AF - Africa 3
OC - Oceania 1
Totale 1.992
Nazione #
IT - Italia 1.720
SG - Singapore 63
US - Stati Uniti d'America 54
CN - Cina 39
VN - Vietnam 32
BR - Brasile 17
FR - Francia 12
DE - Germania 8
HK - Hong Kong 4
ID - Indonesia 4
JP - Giappone 4
IE - Irlanda 3
MX - Messico 3
NL - Olanda 3
AR - Argentina 2
FI - Finlandia 2
GB - Regno Unito 2
IN - India 2
AT - Austria 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
CA - Canada 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
IQ - Iraq 1
MA - Marocco 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RE - Reunion 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.992
Città #
Genova 815
Genoa 417
Bordighera 238
Rapallo 156
Vado Ligure 82
Singapore 25
San Jose 19
Hanoi 12
Lauterbourg 10
Ho Chi Minh City 9
Beijing 7
New York 7
Frankfurt am Main 4
Milan 4
Amsterdam 3
Buffalo 3
Dublin 3
Hong Kong 3
Los Angeles 3
Orem 3
Tokyo 3
Ashburn 2
Da Nang 2
Helsinki 2
Jakarta 2
Santa Clara 2
Turin 2
Xi'an 2
Antipolo City 1
Asnières-sur-Seine 1
Ausonia 1
Berlin 1
Biên Hòa 1
Brasília 1
Casa Branca 1
Catania 1
Caxias do Sul 1
Charlotte 1
Chennai 1
Cherkasy 1
City of London 1
Cochabamba 1
Cotia 1
Ecatepec 1
Fernandópolis 1
Florence 1
Gustavo Adolfo Madero 1
Haiphong 1
Hamad Town 1
Hải Dương 1
Iguape 1
Jaú 1
Jeddah 1
Johannesburg 1
Karbala 1
Laferrere 1
London 1
Montes Claros 1
New Delhi 1
Nogales 1
Novo Gama 1
Novo Hamburgo 1
Olímpia 1
Perugia 1
Port of Spain 1
Posadas 1
Purbalingga 1
Quảng Ngãi 1
Rio de Janeiro 1
Riobamba 1
Saint-Denis 1
Salé 1
Santa Bárbara d'Oeste 1
Santa Luzia 1
Santiago de los Caballeros 1
Schwerin 1
Steinfurt 1
Sydney 1
São João de Meriti 1
São Paulo 1
Thái Bình 1
Toronto 1
Uberlândia 1
Vienna 1
Việt Yên District 1
Vélizy-Villacoublay 1
Witten 1
Totale 1.899
Nome #
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection 492
Protocol of a scoping review assessing injury rates and their determinants among healthcare workers in western countries 173
Inactivated influenza vaccines: recent progress and implications for the elderly 166
Epidemiological and molecular approaches for management of a measles outbreak in Liguria, Italy 151
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. 148
Determinants of invasiveness and ability to cause invasive pneumococcal disease, pneumonia and acute otitis media of different serotypes of Streptococcus pneumoniae. 144
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability. 138
Bacterial carriage and respiratory tract infections in subjects ≥ 60 years during an influenza season: implications for the epidemiology of Community Acquired Pneumonia and influenza vaccine effectiveness 138
Sorveglianza attiva delle infezioni delle alte e basse vie respiratorie in un’ampia coorte di soggetti ≥60 anni durante la stagione influenzale: implicazioni per la valutazione dell’impatto e delle strategie preventive 121
Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance 117
Emergency department syndromic surveillance system for early detection of 5 syndromes: a pilot project in a reference teaching hospital in Genoa, Italy. 115
Influenza vaccination in HIV-positive subjects: latest evidence and future perspective. 97
Totale 2.000
Categoria #
all - tutte 5.705
article - articoli 5.705
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 4 8 7
2021/2022148 3 7 21 15 5 11 11 36 8 14 3 14
2022/2023190 20 23 4 22 19 32 1 11 32 1 17 8
2023/2024321 3 9 2 14 6 12 2 239 5 0 6 23
2024/2025251 15 14 0 18 19 25 24 50 7 6 40 33
2025/2026415 65 9 40 29 80 37 64 23 36 32 0 0
Totale 2.000